---
title: Type 2 Diabetes & Heart Disease Clinical Trial Ipswich | Life Clinical Research
description: Join a clinical trial for adults with type 2 diabetes, high blood pressure, and established heart disease. Reimbursement available. Find out if you qualify.
---

[![Life Clinical Research White](https://www.lcr.health/hs-fs/hubfs/Life-Clinical-Research-White-2.png?width=220&height=60&name=Life-Clinical-Research-White-2.png "Life Clinical Research White")](https://lcr.health)

- [Participants](https://www.lcr.health/participating-in-a-clinical-trial)
- [Sponsors](https://www.lcr.health/sponsors)
- [Referrers](https://www.lcr.health/gps-referring-professionals-life-clinical-research)
- Insights 
    - [About Us](https://www.lcr.health/about-us)
    - [Blog](https://www.lcr.health/blog)
    - [News](https://www.lcr.health/insights/news)
    - [Join Our Team](https://www.lcr.health/insights/work-with-us)
    - [Contact](https://www.lcr.health/contact-us)

<https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#growfast-header__icons--search__mmenu>

[View Trials](https://www.lcr.health/clinical-trials)

[![Life-Clinical-Research-White-2](https://www.lcr.health/hs-fs/hubfs/Life-Clinical-Research-White-2.png?width=200&height=54&name=Life-Clinical-Research-White-2.png "Life-Clinical-Research-White-2")](https://lcr.health)

<https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#growfast-header__mobile-nav__mmenu>

[View Trials](https://www.lcr.health/clinical-trials)

[![Life-Clinical-Research-White-2](https://www.lcr.health/hs-fs/hubfs/Life-Clinical-Research-White-2.png?width=140&height=38&name=Life-Clinical-Research-White-2.png "Life-Clinical-Research-White-2")](https://lcr.health)

- [Participants](https://www.lcr.health/participating-in-a-clinical-trial)
- [Sponsors](https://www.lcr.health/sponsors)
- [Referrers](https://www.lcr.health/gps-referring-professionals-life-clinical-research)
- Insights 
    - [About Us](https://www.lcr.health/about-us)
    - [Blog](https://www.lcr.health/blog)
    - [News](https://www.lcr.health/insights/news)
    - [Join Our Team](https://www.lcr.health/insights/work-with-us)
    - [Contact](https://www.lcr.health/contact-us)

<https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#growfast-header__icons--search__mmenu>

[View Trials](https://www.lcr.health/clinical-trials)

[![Life-Clinical-Research-White-2](https://www.lcr.health/hs-fs/hubfs/Life-Clinical-Research-White-2.png?width=200&height=54&name=Life-Clinical-Research-White-2.png "Life-Clinical-Research-White-2")](https://lcr.health)

<https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#growfast-header__mobile-nav__mmenu>

[View Trials](https://www.lcr.health/clinical-trials)

- [Participants](https://www.lcr.health/participating-in-a-clinical-trial)
- [Sponsors](https://www.lcr.health/sponsors)
- [Referrers](https://www.lcr.health/gps-referring-professionals-life-clinical-research)
- Insights 
    - [About Us](https://www.lcr.health/about-us)
    - [Blog](https://www.lcr.health/blog)
    - [News](https://www.lcr.health/insights/news)
    - [Join Our Team](https://www.lcr.health/insights/work-with-us)
    - [Contact](https://www.lcr.health/contact-us)

# Type 2 Diabetes & Heart Disease Study

For adults living with type 2 diabetes, high blood pressure, and established cardiovascular disease — investigating a new treatment to reduce heart risk.

Ipswich, QLD

[Apply now](https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#apply)

- [Study Details](https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#level-1) 
    - [Description](https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#level-1-2-1)
    - [Eligibility Checklist](https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#level-1-2-2)
    - [What to Expect](https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#level-1-2-3)
    - [Why Join](https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#level-1-2-4)

## Study Details

**Ages**  
18 years or older

**Duration**  
Approximately 4–5 years. Includes around 12 scheduled clinic visits and 6 phone check-ins, with visits every 6 months after the initial phase.

**Compensation**  
Participants are reimbursed for reasonable expenses associated with study visits. Contact our team for current amounts.

**Eligibility**  
See eligibility checklist below. Other criteria apply — our team will check if this study is a good fit for you.

**Locations**  
Ipswich, QLD

 

### Description

Many people living with type 2 diabetes also carry a significantly elevated risk of serious heart events — including heart attack and stroke — particularly when high blood pressure and established cardiovascular disease are also present. Despite current treatments, managing these interconnected risks remains one of the most important challenges in modern medicine.

This clinical study is investigating whether a new investigational medication, taken daily, can help reduce cardiovascular risk in people with this combination of conditions. It works through a mechanism that differs from most existing diabetes and heart medications, offering the potential for a meaningful new treatment option.

As a participant, you will receive the study medication at no cost, regular health monitoring by our experienced clinical team, and reimbursement for your time and travel. All study-related tests and consultations are provided free of charge.

 

### Eligibility Checklist

 

- Type 2 diabetes, currently on treatment
- High blood pressure, currently on treatment
- Established cardiovascular disease — such as a prior heart attack, coronary stent or bypass surgery, prior stroke, or significant peripheral vascular disease

*Other criteria apply. A member of our team will check if this study is a good fit for you*

 

### What to Expect

- You will be randomly assigned to receive either the investigational study medication or a placebo — neither you nor the clinical team will know which you have received
- An initial screening visit to confirm your eligibility, including blood tests, an ECG, and a medical history review — at no cost to you
- Regular clinic visits every six months for health checks, blood tests, vital signs, and medication supply
- Six-monthly phone check-ins between visits to monitor your safety and wellbeing
- All study medications, tests, and consultations are provided at no cost to you
- Reimbursement for your time and reasonable travel costs associated with each visit
- You are free to withdraw at any time, for any reason, without affecting your usual medical care

 

### Why Join

**Early access:** Access an investigational treatment not yet publicly available — at no cost to you.

**Close monitoring:** Regular health checks by our experienced Queensland clinical team throughout.

**Reimbursement:** Receive reimbursement for your time and reasonable travel costs per visit.

**Help others:** Contribute to research that could help millions of Australians living with heart disease and diabetes.

Footer note: Your privacy is important. All personal information will be kept strictly confidential.

 

### Apply Now

![Life-Clinical-Research-White-2](https://www.lcr.health/hs-fs/hubfs/Life-Clinical-Research-White-2.png?width=166&height=45&name=Life-Clinical-Research-White-2.png)

Bridging Breakthroughs  
& Communities.

[Follow us on Facebook](https://www.linkedin.com/company/life-clinical/) [Follow us on X](https://x.com/lcr_health) [Follow us on Facebook](https://www.facebook.com/profile.php?id=61555251590456)

Copyright © Life Clinical Research.

- [Terms & Conditions](https://www.lcr.health/terms-and-conditions)
- [Privacy Policy](https://www.lcr.health/privacy-policy)
- [Privacy Policy - Participants](https://www.lcr.health/privacy-policy-participants)
- [Contact](https://www.lcr.health/contact-us)

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.lcr.health/#organization",
  "@type" : "MedicalOrganization",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "AU",
    "addressLocality" : "Ipswich",
    "addressRegion" : "QLD",
    "postalCode" : "4305",
    "streetAddress" : "33 Thorn Street"
  },
  "alternateName" : "LCR",
  "areaServed" : {
    "@type" : "AdministrativeArea",
    "name" : "South-East Queensland"
  },
  "department" : [ {
    "@id" : "https://www.lcr.health/#ipswich-site"
  }, {
    "@id" : "https://www.lcr.health/#eastbrisbane-site"
  } ],
  "description" : "Life Clinical Research is a clinical trial network giving patients early access to novel treatments and sponsors a high-performing research partner in South-East Queensland.",
  "email" : "hello@lcr.health",
  "foundingDate" : "2023",
  "image" : "https://www.lcr.health/hubfs/open-graph.png",
  "logo" : "https://www.lcr.health/hubfs/life-clinical-research.svg",
  "medicalSpecialty" : [ "Cardiovascular", "Endocrine", "Infectious", "Rheumatologic" ],
  "name" : "Life Clinical Research",
  "sameAs" : [ "https://www.linkedin.com/company/life-clinical/", "https://x.com/lcr_health", "https://www.facebook.com/profile.php?id=61555251590456" ],
  "telephone" : "+61-7-3180-8045",
  "url" : "https://www.lcr.health"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.lcr.health/#website",
  "@type" : "WebSite",
  "inLanguage" : "en-AU",
  "name" : "Life Clinical Research",
  "publisher" : {
    "@id" : "https://www.lcr.health/#organization"
  },
  "url" : "https://www.lcr.health"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.lcr.health/#ipswich-site",
  "@type" : "MedicalClinic",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "AU",
    "addressLocality" : "Ipswich",
    "addressRegion" : "QLD",
    "postalCode" : "4305",
    "streetAddress" : "33 Thorn Street"
  },
  "description" : "Co-located with the Ipswich Cardiac Centre, offering on-site echocardiography, exercise stress testing, Holter monitoring, and 24-hour ambulatory blood pressure monitoring.",
  "geo" : {
    "@type" : "GeoCoordinates",
    "latitude" : -27.616995,
    "longitude" : 152.764374
  },
  "medicalSpecialty" : [ "Cardiovascular", "Endocrine", "Rheumatologic" ],
  "name" : "Life Clinical Research - Ipswich",
  "parentOrganization" : {
    "@id" : "https://www.lcr.health/#organization"
  },
  "telephone" : "+61-7-3180-8045"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.lcr.health/#eastbrisbane-site",
  "@type" : "MedicalClinic",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "AU",
    "addressLocality" : "East Brisbane",
    "addressRegion" : "QLD",
    "postalCode" : "4169",
    "streetAddress" : "26 Didsbury Street"
  },
  "description" : "Operates alongside Q Cardiology, extending specialist-integrated research care to patients across Brisbane's inner south-east.",
  "medicalSpecialty" : [ "Cardiovascular", "Infectious", "Psychiatric" ],
  "name" : "Life Clinical Research - East Brisbane",
  "parentOrganization" : {
    "@id" : "https://www.lcr.health/#organization"
  },
  "telephone" : "+61-7-3180-8045"
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich#trial",
  "@type" : "MedicalTrial",
  "description" : "A clinical trial investigating whether a new investigational daily medication, working through a mechanism different from most existing diabetes and heart medications, can help reduce cardiovascular risk in adults with type 2 diabetes, high blood pressure, and established cardiovascular disease. Participants are randomly assigned in a double-blind design to receive either the investigational medication or a placebo, with regular health monitoring over an anticipated 4 to 5 years.",
  "healthCondition" : [ {
    "@type" : "MedicalCondition",
    "name" : "Type 2 diabetes"
  }, {
    "@type" : "MedicalCondition",
    "name" : "Hypertension"
  }, {
    "@type" : "MedicalCondition",
    "name" : "Cardiovascular disease"
  } ],
  "mainEntityOfPage" : "https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich",
  "name" : "Type 2 Diabetes & Heart Disease Study",
  "status" : "https://schema.org/Recruiting",
  "studyLocation" : {
    "@id" : "https://www.lcr.health/#ipswich-site"
  },
  "studySubject" : {
    "@type" : "MedicalEntity",
    "name" : "Adults aged 18+ with type 2 diabetes currently on treatment, high blood pressure currently on treatment, and established cardiovascular disease (e.g. prior heart attack, coronary stent or bypass, prior stroke, or significant peripheral vascular disease)"
  },
  "trialDesign" : [ "https://schema.org/RandomizedTrial", "https://schema.org/DoubleBlindedTrial", "https://schema.org/PlaceboControlledTrial" ],
  "url" : "https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "BreadcrumbList",
  "itemListElement" : [ {
    "@type" : "ListItem",
    "item" : "https://www.lcr.health/",
    "name" : "Home",
    "position" : 1
  }, {
    "@type" : "ListItem",
    "item" : "https://www.lcr.health/clinical-trials",
    "name" : "Clinical Trials",
    "position" : 2
  }, {
    "@type" : "ListItem",
    "item" : "https://www.lcr.health/clinical-trials/type-2-diabetes-heart-disease-study-ipswich",
    "name" : "Type 2 Diabetes & Heart Disease Study",
    "position" : 3
  } ]
}
```